The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cold Medicine Market Research Report 2025
Synopsis
Cold is the most common disease, can come on all the year round.At present, there are many kinds of cold medicine in the market, most of which can be bought in the drugstore.Common medicaments are like capsule of quick effect cold, cold is tong, kang beidu.
The global Cold Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cold Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold Medicine.
Report Scope
The Cold Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cold Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wyeth (Pfizer)
Atley Pharmaceuticals
Vertical Pharmaceuticals
Novartis
Merck
Sanofi
Johnson & Johnson
Toray Industries
Bayer
Bristol-Myers Squibb
Tongrentang Pharmaceutical
Jinghua Pharmaceutical Group
Jiangxi Heying Pharmaceutical
Diao Group Chengdu Pharmaceutical
Shanghai Shangyao Xinyi Pharmaceutical
Harbin Children Pharmaceutical
Huarun Sanjiu Pharmaceutical
Xinjiang Quanan Pharmaceutical
Jiangsu Huayang Pharmaceutical
Nanjing Chenggong Pharmaceutical
Beijing Jiulong Pharmaceutical
Livzon Pharmaceutical Group
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm
CSPC
Segment by Type
Drops
Dropping Pill
Capsule
Granules
Tablets
Solution
Syrups
Pills
Injection
Other
Segment by Application
Baby
Young Children
Preschooler
School-Age Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cold Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cold is the most common disease, can come on all the year round.At present, there are many kinds of cold medicine in the market, most of which can be bought in the drugstore.Common medicaments are like capsule of quick effect cold, cold is tong, kang beidu.
The global Cold Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cold Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold Medicine.
Report Scope
The Cold Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cold Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wyeth (Pfizer)
Atley Pharmaceuticals
Vertical Pharmaceuticals
Novartis
Merck
Sanofi
Johnson & Johnson
Toray Industries
Bayer
Bristol-Myers Squibb
Tongrentang Pharmaceutical
Jinghua Pharmaceutical Group
Jiangxi Heying Pharmaceutical
Diao Group Chengdu Pharmaceutical
Shanghai Shangyao Xinyi Pharmaceutical
Harbin Children Pharmaceutical
Huarun Sanjiu Pharmaceutical
Xinjiang Quanan Pharmaceutical
Jiangsu Huayang Pharmaceutical
Nanjing Chenggong Pharmaceutical
Beijing Jiulong Pharmaceutical
Livzon Pharmaceutical Group
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm
CSPC
Segment by Type
Drops
Dropping Pill
Capsule
Granules
Tablets
Solution
Syrups
Pills
Injection
Other
Segment by Application
Baby
Young Children
Preschooler
School-Age Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cold Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drops
1.2.3 Dropping Pill
1.2.4 Capsule
1.2.5 Granules
1.2.6 Tablets
1.2.7 Solution
1.2.8 Syrups
1.2.9 Pills
1.2.10 Injection
1.2.11 Other
1.3 Market by Application
1.3.1 Global Cold Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Baby
1.3.3 Young Children
1.3.4 Preschooler
1.3.5 School-Age Children
1.3.6 Adult
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold Medicine Market Perspective (2019-2030)
2.2 Cold Medicine Growth Trends by Region
2.2.1 Global Cold Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cold Medicine Historic Market Size by Region (2019-2024)
2.2.3 Cold Medicine Forecasted Market Size by Region (2025-2030)
2.3 Cold Medicine Market Dynamics
2.3.1 Cold Medicine Industry Trends
2.3.2 Cold Medicine Market Drivers
2.3.3 Cold Medicine Market Challenges
2.3.4 Cold Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Medicine Players by Revenue
3.1.1 Global Top Cold Medicine Players by Revenue (2019-2024)
3.1.2 Global Cold Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Cold Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cold Medicine Revenue
3.4 Global Cold Medicine Market Concentration Ratio
3.4.1 Global Cold Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Medicine Revenue in 2023
3.5 Cold Medicine Key Players Head office and Area Served
3.6 Key Players Cold Medicine Product Solution and Service
3.7 Date of Enter into Cold Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold Medicine Breakdown Data by Type
4.1 Global Cold Medicine Historic Market Size by Type (2019-2024)
4.2 Global Cold Medicine Forecasted Market Size by Type (2025-2030)
5 Cold Medicine Breakdown Data by Application
5.1 Global Cold Medicine Historic Market Size by Application (2019-2024)
5.2 Global Cold Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cold Medicine Market Size (2019-2030)
6.2 North America Cold Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cold Medicine Market Size by Country (2019-2024)
6.4 North America Cold Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold Medicine Market Size (2019-2030)
7.2 Europe Cold Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cold Medicine Market Size by Country (2019-2024)
7.4 Europe Cold Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold Medicine Market Size (2019-2030)
8.2 Asia-Pacific Cold Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cold Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Cold Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cold Medicine Market Size (2019-2030)
9.2 Latin America Cold Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cold Medicine Market Size by Country (2019-2024)
9.4 Latin America Cold Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Medicine Market Size (2019-2030)
10.2 Middle East & Africa Cold Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cold Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Cold Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wyeth (Pfizer)
11.1.1 Wyeth (Pfizer) Company Detail
11.1.2 Wyeth (Pfizer) Business Overview
11.1.3 Wyeth (Pfizer) Cold Medicine Introduction
11.1.4 Wyeth (Pfizer) Revenue in Cold Medicine Business (2019-2024)
11.1.5 Wyeth (Pfizer) Recent Development
11.2 Atley Pharmaceuticals
11.2.1 Atley Pharmaceuticals Company Detail
11.2.2 Atley Pharmaceuticals Business Overview
11.2.3 Atley Pharmaceuticals Cold Medicine Introduction
11.2.4 Atley Pharmaceuticals Revenue in Cold Medicine Business (2019-2024)
11.2.5 Atley Pharmaceuticals Recent Development
11.3 Vertical Pharmaceuticals
11.3.1 Vertical Pharmaceuticals Company Detail
11.3.2 Vertical Pharmaceuticals Business Overview
11.3.3 Vertical Pharmaceuticals Cold Medicine Introduction
11.3.4 Vertical Pharmaceuticals Revenue in Cold Medicine Business (2019-2024)
11.3.5 Vertical Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Cold Medicine Introduction
11.4.4 Novartis Revenue in Cold Medicine Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Cold Medicine Introduction
11.5.4 Merck Revenue in Cold Medicine Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Cold Medicine Introduction
11.6.4 Sanofi Revenue in Cold Medicine Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Cold Medicine Introduction
11.7.4 Johnson & Johnson Revenue in Cold Medicine Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 Toray Industries
11.8.1 Toray Industries Company Detail
11.8.2 Toray Industries Business Overview
11.8.3 Toray Industries Cold Medicine Introduction
11.8.4 Toray Industries Revenue in Cold Medicine Business (2019-2024)
11.8.5 Toray Industries Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Cold Medicine Introduction
11.9.4 Bayer Revenue in Cold Medicine Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Detail
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Cold Medicine Introduction
11.10.4 Bristol-Myers Squibb Revenue in Cold Medicine Business (2019-2024)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Tongrentang Pharmaceutical
11.11.1 Tongrentang Pharmaceutical Company Detail
11.11.2 Tongrentang Pharmaceutical Business Overview
11.11.3 Tongrentang Pharmaceutical Cold Medicine Introduction
11.11.4 Tongrentang Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.11.5 Tongrentang Pharmaceutical Recent Development
11.12 Jinghua Pharmaceutical Group
11.12.1 Jinghua Pharmaceutical Group Company Detail
11.12.2 Jinghua Pharmaceutical Group Business Overview
11.12.3 Jinghua Pharmaceutical Group Cold Medicine Introduction
11.12.4 Jinghua Pharmaceutical Group Revenue in Cold Medicine Business (2019-2024)
11.12.5 Jinghua Pharmaceutical Group Recent Development
11.13 Jiangxi Heying Pharmaceutical
11.13.1 Jiangxi Heying Pharmaceutical Company Detail
11.13.2 Jiangxi Heying Pharmaceutical Business Overview
11.13.3 Jiangxi Heying Pharmaceutical Cold Medicine Introduction
11.13.4 Jiangxi Heying Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.13.5 Jiangxi Heying Pharmaceutical Recent Development
11.14 Diao Group Chengdu Pharmaceutical
11.14.1 Diao Group Chengdu Pharmaceutical Company Detail
11.14.2 Diao Group Chengdu Pharmaceutical Business Overview
11.14.3 Diao Group Chengdu Pharmaceutical Cold Medicine Introduction
11.14.4 Diao Group Chengdu Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.14.5 Diao Group Chengdu Pharmaceutical Recent Development
11.15 Shanghai Shangyao Xinyi Pharmaceutical
11.15.1 Shanghai Shangyao Xinyi Pharmaceutical Company Detail
11.15.2 Shanghai Shangyao Xinyi Pharmaceutical Business Overview
11.15.3 Shanghai Shangyao Xinyi Pharmaceutical Cold Medicine Introduction
11.15.4 Shanghai Shangyao Xinyi Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.15.5 Shanghai Shangyao Xinyi Pharmaceutical Recent Development
11.16 Harbin Children Pharmaceutical
11.16.1 Harbin Children Pharmaceutical Company Detail
11.16.2 Harbin Children Pharmaceutical Business Overview
11.16.3 Harbin Children Pharmaceutical Cold Medicine Introduction
11.16.4 Harbin Children Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.16.5 Harbin Children Pharmaceutical Recent Development
11.17 Huarun Sanjiu Pharmaceutical
11.17.1 Huarun Sanjiu Pharmaceutical Company Detail
11.17.2 Huarun Sanjiu Pharmaceutical Business Overview
11.17.3 Huarun Sanjiu Pharmaceutical Cold Medicine Introduction
11.17.4 Huarun Sanjiu Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.17.5 Huarun Sanjiu Pharmaceutical Recent Development
11.18 Xinjiang Quanan Pharmaceutical
11.18.1 Xinjiang Quanan Pharmaceutical Company Detail
11.18.2 Xinjiang Quanan Pharmaceutical Business Overview
11.18.3 Xinjiang Quanan Pharmaceutical Cold Medicine Introduction
11.18.4 Xinjiang Quanan Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.18.5 Xinjiang Quanan Pharmaceutical Recent Development
11.19 Jiangsu Huayang Pharmaceutical
11.19.1 Jiangsu Huayang Pharmaceutical Company Detail
11.19.2 Jiangsu Huayang Pharmaceutical Business Overview
11.19.3 Jiangsu Huayang Pharmaceutical Cold Medicine Introduction
11.19.4 Jiangsu Huayang Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.19.5 Jiangsu Huayang Pharmaceutical Recent Development
11.20 Nanjing Chenggong Pharmaceutical
11.20.1 Nanjing Chenggong Pharmaceutical Company Detail
11.20.2 Nanjing Chenggong Pharmaceutical Business Overview
11.20.3 Nanjing Chenggong Pharmaceutical Cold Medicine Introduction
11.20.4 Nanjing Chenggong Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.20.5 Nanjing Chenggong Pharmaceutical Recent Development
11.21 Beijing Jiulong Pharmaceutical
11.21.1 Beijing Jiulong Pharmaceutical Company Detail
11.21.2 Beijing Jiulong Pharmaceutical Business Overview
11.21.3 Beijing Jiulong Pharmaceutical Cold Medicine Introduction
11.21.4 Beijing Jiulong Pharmaceutical Revenue in Cold Medicine Business (2019-2024)
11.21.5 Beijing Jiulong Pharmaceutical Recent Development
11.22 Livzon Pharmaceutical Group
11.22.1 Livzon Pharmaceutical Group Company Detail
11.22.2 Livzon Pharmaceutical Group Business Overview
11.22.3 Livzon Pharmaceutical Group Cold Medicine Introduction
11.22.4 Livzon Pharmaceutical Group Revenue in Cold Medicine Business (2019-2024)
11.22.5 Livzon Pharmaceutical Group Recent Development
11.23 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.23.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Detail
11.23.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.23.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Cold Medicine Introduction
11.23.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Cold Medicine Business (2019-2024)
11.23.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
11.24 Sinopharm
11.24.1 Sinopharm Company Detail
11.24.2 Sinopharm Business Overview
11.24.3 Sinopharm Cold Medicine Introduction
11.24.4 Sinopharm Revenue in Cold Medicine Business (2019-2024)
11.24.5 Sinopharm Recent Development
11.25 CSPC
11.25.1 CSPC Company Detail
11.25.2 CSPC Business Overview
11.25.3 CSPC Cold Medicine Introduction
11.25.4 CSPC Revenue in Cold Medicine Business (2019-2024)
11.25.5 CSPC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cold Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Drops
Table 3. Key Players of Dropping Pill
Table 4. Key Players of Capsule
Table 5. Key Players of Granules
Table 6. Key Players of Tablets
Table 7. Key Players of Solution
Table 8. Key Players of Syrups
Table 9. Key Players of Pills
Table 10. Key Players of Injection
Table 11. Key Players of Other
Table 12. Global Cold Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Cold Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Cold Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Cold Medicine Market Share by Region (2019-2024)
Table 16. Global Cold Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Cold Medicine Market Share by Region (2025-2030)
Table 18. Cold Medicine Market Trends
Table 19. Cold Medicine Market Drivers
Table 20. Cold Medicine Market Challenges
Table 21. Cold Medicine Market Restraints
Table 22. Global Cold Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 23. Global Cold Medicine Market Share by Players (2019-2024)
Table 24. Global Top Cold Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Medicine as of 2023)
Table 25. Ranking of Global Top Cold Medicine Companies by Revenue (US$ Million) in 2023
Table 26. Global 5 Largest Players Market Share by Cold Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Cold Medicine Product Solution and Service
Table 29. Date of Enter into Cold Medicine Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Cold Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 32. Global Cold Medicine Revenue Market Share by Type (2019-2024)
Table 33. Global Cold Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 34. Global Cold Medicine Revenue Market Share by Type (2025-2030)
Table 35. Global Cold Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 36. Global Cold Medicine Revenue Market Share by Application (2019-2024)
Table 37. Global Cold Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 38. Global Cold Medicine Revenue Market Share by Application (2025-2030)
Table 39. North America Cold Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. North America Cold Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 41. North America Cold Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 42. Europe Cold Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Cold Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Cold Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 45. Asia-Pacific Cold Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 46. Asia-Pacific Cold Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 47. Asia-Pacific Cold Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 48. Latin America Cold Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Latin America Cold Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 50. Latin America Cold Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 51. Middle East & Africa Cold Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 52. Middle East & Africa Cold Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 53. Middle East & Africa Cold Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 54. Wyeth (Pfizer) Company Detail
Table 55. Wyeth (Pfizer) Business Overview
Table 56. Wyeth (Pfizer) Cold Medicine Product
Table 57. Wyeth (Pfizer) Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 58. Wyeth (Pfizer) Recent Development
Table 59. Atley Pharmaceuticals Company Detail
Table 60. Atley Pharmaceuticals Business Overview
Table 61. Atley Pharmaceuticals Cold Medicine Product
Table 62. Atley Pharmaceuticals Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 63. Atley Pharmaceuticals Recent Development
Table 64. Vertical Pharmaceuticals Company Detail
Table 65. Vertical Pharmaceuticals Business Overview
Table 66. Vertical Pharmaceuticals Cold Medicine Product
Table 67. Vertical Pharmaceuticals Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 68. Vertical Pharmaceuticals Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Cold Medicine Product
Table 72. Novartis Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Merck Company Detail
Table 75. Merck Business Overview
Table 76. Merck Cold Medicine Product
Table 77. Merck Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Sanofi Company Detail
Table 80. Sanofi Business Overview
Table 81. Sanofi Cold Medicine Product
Table 82. Sanofi Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 83. Sanofi Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Cold Medicine Product
Table 87. Johnson & Johnson Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Toray Industries Company Detail
Table 90. Toray Industries Business Overview
Table 91. Toray Industries Cold Medicine Product
Table 92. Toray Industries Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 93. Toray Industries Recent Development
Table 94. Bayer Company Detail
Table 95. Bayer Business Overview
Table 96. Bayer Cold Medicine Product
Table 97. Bayer Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 98. Bayer Recent Development
Table 99. Bristol-Myers Squibb Company Detail
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Cold Medicine Product
Table 102. Bristol-Myers Squibb Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Tongrentang Pharmaceutical Company Detail
Table 105. Tongrentang Pharmaceutical Business Overview
Table 106. Tongrentang Pharmaceutical Cold Medicine Product
Table 107. Tongrentang Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 108. Tongrentang Pharmaceutical Recent Development
Table 109. Jinghua Pharmaceutical Group Company Detail
Table 110. Jinghua Pharmaceutical Group Business Overview
Table 111. Jinghua Pharmaceutical Group Cold Medicine Product
Table 112. Jinghua Pharmaceutical Group Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 113. Jinghua Pharmaceutical Group Recent Development
Table 114. Jiangxi Heying Pharmaceutical Company Detail
Table 115. Jiangxi Heying Pharmaceutical Business Overview
Table 116. Jiangxi Heying Pharmaceutical Cold Medicine Product
Table 117. Jiangxi Heying Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 118. Jiangxi Heying Pharmaceutical Recent Development
Table 119. Diao Group Chengdu Pharmaceutical Company Detail
Table 120. Diao Group Chengdu Pharmaceutical Business Overview
Table 121. Diao Group Chengdu Pharmaceutical Cold Medicine Product
Table 122. Diao Group Chengdu Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 123. Diao Group Chengdu Pharmaceutical Recent Development
Table 124. Shanghai Shangyao Xinyi Pharmaceutical Company Detail
Table 125. Shanghai Shangyao Xinyi Pharmaceutical Business Overview
Table 126. Shanghai Shangyao Xinyi Pharmaceutical Cold Medicine Product
Table 127. Shanghai Shangyao Xinyi Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 128. Shanghai Shangyao Xinyi Pharmaceutical Recent Development
Table 129. Harbin Children Pharmaceutical Company Detail
Table 130. Harbin Children Pharmaceutical Business Overview
Table 131. Harbin Children Pharmaceutical Cold Medicine Product
Table 132. Harbin Children Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 133. Harbin Children Pharmaceutical Recent Development
Table 134. Huarun Sanjiu Pharmaceutical Company Detail
Table 135. Huarun Sanjiu Pharmaceutical Business Overview
Table 136. Huarun Sanjiu Pharmaceutical Cold Medicine Product
Table 137. Huarun Sanjiu Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 138. Huarun Sanjiu Pharmaceutical Recent Development
Table 139. Xinjiang Quanan Pharmaceutical Company Detail
Table 140. Xinjiang Quanan Pharmaceutical Business Overview
Table 141. Xinjiang Quanan Pharmaceutical Cold Medicine Product
Table 142. Xinjiang Quanan Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 143. Xinjiang Quanan Pharmaceutical Recent Development
Table 144. Jiangsu Huayang Pharmaceutical Company Detail
Table 145. Jiangsu Huayang Pharmaceutical Business Overview
Table 146. Jiangsu Huayang Pharmaceutical Cold Medicine Product
Table 147. Jiangsu Huayang Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 148. Jiangsu Huayang Pharmaceutical Recent Development
Table 149. Nanjing Chenggong Pharmaceutical Company Detail
Table 150. Nanjing Chenggong Pharmaceutical Business Overview
Table 151. Nanjing Chenggong Pharmaceutical Cold Medicine Product
Table 152. Nanjing Chenggong Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 153. Nanjing Chenggong Pharmaceutical Recent Development
Table 154. Beijing Jiulong Pharmaceutical Company Detail
Table 155. Beijing Jiulong Pharmaceutical Business Overview
Table 156. Beijing Jiulong Pharmaceutical Cold Medicine Product
Table 157. Beijing Jiulong Pharmaceutical Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 158. Beijing Jiulong Pharmaceutical Recent Development
Table 159. Livzon Pharmaceutical Group Company Detail
Table 160. Livzon Pharmaceutical Group Business Overview
Table 161. Livzon Pharmaceutical Group Cold Medicine Product
Table 162. Livzon Pharmaceutical Group Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 163. Livzon Pharmaceutical Group Recent Development
Table 164. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Detail
Table 165. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 166. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Cold Medicine Product
Table 167. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 168. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 169. Sinopharm Company Detail
Table 170. Sinopharm Business Overview
Table 171. Sinopharm Cold Medicine Product
Table 172. Sinopharm Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 173. Sinopharm Recent Development
Table 174. CSPC Company Detail
Table 175. CSPC Business Overview
Table 176. CSPC Cold Medicine Product
Table 177. CSPC Revenue in Cold Medicine Business (2019-2024) & (US$ Million)
Table 178. CSPC Recent Development
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cold Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cold Medicine Market Share by Type: 2023 VS 2030
Figure 3. Drops Features
Figure 4. Dropping Pill Features
Figure 5. Capsule Features
Figure 6. Granules Features
Figure 7. Tablets Features
Figure 8. Solution Features
Figure 9. Syrups Features
Figure 10. Pills Features
Figure 11. Injection Features
Figure 12. Other Features
Figure 13. Global Cold Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 14. Global Cold Medicine Market Share by Application: 2023 VS 2030
Figure 15. Baby Case Studies
Figure 16. Young Children Case Studies
Figure 17. Preschooler Case Studies
Figure 18. School-Age Children Case Studies
Figure 19. Adult Case Studies
Figure 20. Cold Medicine Report Years Considered
Figure 21. Global Cold Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 22. Global Cold Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 23. Global Cold Medicine Market Share by Region: 2023 VS 2030
Figure 24. Global Cold Medicine Market Share by Players in 2023
Figure 25. Global Top Cold Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Medicine as of 2023)
Figure 26. The Top 10 and 5 Players Market Share by Cold Medicine Revenue in 2023
Figure 27. North America Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. North America Cold Medicine Market Share by Country (2019-2030)
Figure 29. United States Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Canada Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Cold Medicine Market Share by Country (2019-2030)
Figure 33. Germany Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Asia-Pacific Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Asia-Pacific Cold Medicine Market Share by Region (2019-2030)
Figure 41. China Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Japan Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Latin America Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Latin America Cold Medicine Market Share by Country (2019-2030)
Figure 49. Mexico Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Brazil Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Cold Medicine Market Share by Country (2019-2030)
Figure 53. Turkey Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Cold Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Wyeth (Pfizer) Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 56. Atley Pharmaceuticals Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 57. Vertical Pharmaceuticals Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 58. Novartis Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 59. Merck Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 60. Sanofi Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 61. Johnson & Johnson Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 62. Toray Industries Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 63. Bayer Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 65. Tongrentang Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 66. Jinghua Pharmaceutical Group Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 67. Jiangxi Heying Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 68. Diao Group Chengdu Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 69. Shanghai Shangyao Xinyi Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 70. Harbin Children Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 71. Huarun Sanjiu Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 72. Xinjiang Quanan Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 73. Jiangsu Huayang Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 74. Nanjing Chenggong Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 75. Beijing Jiulong Pharmaceutical Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 76. Livzon Pharmaceutical Group Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 77. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 78. Sinopharm Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 79. CSPC Revenue Growth Rate in Cold Medicine Business (2019-2024)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
